MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Apathy and impulsivity co-occur in Huntington’s disease

L. Morris, K. Horne, L. Paermentier, C. Buchanan, M. Macaskill, D. Myall, M. Husain, R. Roxburgh, T. Anderson, C. Le Heron (Christchurch, New Zealand)

Meeting: 2023 International Congress

Abstract Number: 893

Keywords: Apathy, Neurobehavioral disorders

Category: Huntington's Disease

Objective: To determine whether apathy and impulsivity co-occur in people with Huntington’s disease.

Background: Apathy and impulsivity are debilitating behavioural changes which often occur in Huntington’s disease. Once considered to be at opposite ends of a behavioural spectrum, their co-occurrence in individuals is now recognised in a number of neurological and psychiatric disorders. This suggests a shared underlying mechanism, which we recently proposed could be disruptions to the way in which rewards and costs are integrated in the brain to drive behaviour (cost-benefit decision making). However in Huntington’s disease, where both these behavioural disturbances have marked impact on people and their families, the co-occurrence of these problems has not been investigated.

Method: Carriers of the Huntington’s gene expansion (premanifest to mild manifest disease; n = 42) were recruited from two movement disorder clinics in New Zealand, along with healthy controls (n = 20). Measures of apathy (Apathy Evaluation Scale & Apathy Motivation Index) and impulsivity (Barratt Impulsiveness scale-11 & UPPS-P impulsivity scale), along with mood, cognition, clinical and quality of life measures were collected. Apathy and impulsivity measures were each reduced to a single metric per patient using principal component analysis. Pearson correlation and multiple linear regression models determined whether an association existed between apathy and impulsivity, and potential influence of other covariates.

Results: Apathy and impulsivity were correlated (r = .54, p < 0.001, [95% CI, 0.28-0.72]) in Huntington’s disease, with this association remaining after controlling for depressive symptoms, disease severity and cognitive function. Furthermore, apathy and depressive symptoms were associated with poorer quality of life, after controlling for motor disease severity and cognitive function.

Conclusion: Apathy and impulsivity co-occur in individuals with Huntington’s disease and pre-manifest gene carriers and have a significant impact on wellbeing. Their co-occurrence in HD is consistent with a shared mechanistic underpinning. Future research should focus on elucidating these mechanisms with the goal of meeting an important but unmet treatment need in this population.

pca plot

To cite this abstract in AMA style:

L. Morris, K. Horne, L. Paermentier, C. Buchanan, M. Macaskill, D. Myall, M. Husain, R. Roxburgh, T. Anderson, C. Le Heron. Apathy and impulsivity co-occur in Huntington’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/apathy-and-impulsivity-co-occur-in-huntingtons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/apathy-and-impulsivity-co-occur-in-huntingtons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley